A 70-year-old with HFrEF (LVEF 30%) remains symptomatic (NYHA II) on optimal doses of ACE inhibitor and beta-blocker. What is the next disease-modifyi...

Question

A 70-year-old with HFrEF (LVEF 30%) remains symptomatic (NYHA II) on optimal doses of ACE inhibitor and beta-blocker. What is the next disease-modifying therapy to add in primary care after specialist advice if needed?

Accepted Answer

Dapagliflozin (SGLT2 inhibitor)

Answer

Ivabradine

Answer

Amiodarone

Answer

Loop diuretic uptitration

Answer

Digoxin

ukmla MCQ (SBA): Heart Failure (HFrEF)

A 70-year-old with HFrEF (LVEF 30%) remains symptomatic (NYHA II) on optimal doses of ACE inhibitor and beta-blocker. What is the next disease-modifying therapy to add in primary care after specialist advice if needed?